Regulation of p53 and NF-κB transactivation activities by DGKζ in catalytic activity-dependent and -independent manners

被引:6
|
作者
Tanaka, Toshiaki [1 ]
Nakano, Tomoyuki [1 ]
Hozumi, Yasukazu [2 ]
Martelli, Alberto M. [3 ]
Goto, Kaoru [1 ]
机构
[1] Yamagata Univ, Dept Anat & Cell Biol, Sch Med, Iida Nishi 2-2-2, Yamagata 9909585, Japan
[2] Akita Univ, Dept Cell Biol & Morphol, Grad Sch Med, Akita 0108543, Japan
[3] Univ Bologna, Dept Biomed & Neuromotor Sci, Via Irnerio 48, I-40126 Bologna, Italy
来源
关键词
Catalytic activity; CBP; DGK; NF-kappa B; p53; Transcription; DIACYLGLYCEROL KINASE-ZETA; NUCLEOSOME ASSEMBLY PROTEINS; CREB-BINDING-PROTEIN; RNA HELICASE; NUCLEAR-LOCALIZATION; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; CYCLIN D1; CBP; P68;
D O I
10.1016/j.bbamcr.2021.118953
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diacylglycerol kinase (DGK) constitutes a family of enzymes that phosphorylate diacylglycerol to phosphatidic acid (PA). These lipids serve as second messengers, thereby activating distinct downstream cascades and different cellular responses. Therefore, DG-to-PA conversion activity induces a phase transition of signaling pathways. One member of the family, DGK zeta, is involved closely with stress responses. Morphological data showing that DGK zeta localizes predominantly to the nucleus and that it shuttles between the nucleus and the cytoplasm implicate DGK. in the regulation of transcription factors during stress responses. Tumor suppressor p53 and NF-kappa B are major stress-responsive transcription factors. They exert opposing effects on cellular pathophysiology. Herein, we summarize DGK zeta catalytic activity-dependent and -independent regulatory mechanisms of p53 and NF-kappa B transactivation activities, including p53 degradation and NF-kappa B nuclear translocation. We also discuss how each component of DGK zeta-interacting protein complex modulates the specificity and selectivity of target gene expression.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Additive effect between NF-κB subunits and p53 protein for transcriptional activation of human p53 promoter
    Benoit, V
    Hellin, AC
    Huygen, S
    Gielen, J
    Bours, V
    Merville, MP
    ONCOGENE, 2000, 19 (41) : 4787 - 4794
  • [32] Additive effect between NF-κB subunits and p53 protein for transcriptional activation of human p53 promoter
    Valerie Benoit
    Anne-Cécile Hellin
    Sandra Huygen
    Jacques Gielen
    Vincent Bours
    Marie-Paule Merville
    Oncogene, 2000, 19 : 4787 - 4794
  • [34] Effects of IκBα and its mutants on NF-κB and p53 signaling pathways
    Li, Xian
    Xing, Da
    Wang, Lu
    Zhu, De-Bin
    Zhang, Lan
    Chen, Xiao-Jia
    Sun, Fen-Yong
    Hong, An
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (41) : 6658 - 6664
  • [35] DNA-dependent protein kinase catalytic subunit binds to the transactivation domain 1 of NF-κB p65
    Hasegawa, Yuta
    Asada, Shinichi
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2023, 35
  • [36] Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation
    D Pan
    L-Z Pan
    R Hill
    P Marcato
    M Shmulevitz
    L T Vassilev
    P W K Lee
    British Journal of Cancer, 2011, 105 : 1012 - 1022
  • [37] Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation
    Pan, D.
    Pan, L-Z
    Hill, R.
    Marcato, P.
    Shmulevitz, M.
    Vassilev, L. T.
    Lee, P. W. K.
    BRITISH JOURNAL OF CANCER, 2011, 105 (07) : 1012 - 1022
  • [38] Signaling from p53 to NF-κB determines the chemotherapy responsiveness of neuroblastoma
    Armstrong, Michael B.
    Bian, Xin
    Liu, Yihong
    Subramanian, Chitra
    Ratanaproeksa, Anthony B.
    Shao, Feng
    Yu, Victor C.
    Kwok, Roland P. S.
    Opipari, Anthony W., Jr.
    Castle, Valerie P.
    NEOPLASIA, 2006, 8 (11): : 967 - 977
  • [39] Cross talk between stimulated NF-κB and the tumor suppressor p53
    Schneider, G.
    Henrich, A.
    Greiner, G.
    Wolf, V.
    Lovas, A.
    Wieczorek, M.
    Wagner, T.
    Reichardt, S.
    von Werder, A.
    Schmid, R. M.
    Weih, F.
    Heinzel, T.
    Saur, D.
    Kraemer, O. H.
    ONCOGENE, 2010, 29 (19) : 2795 - 2806
  • [40] Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
    Rocha, S
    Garrett, MD
    Campbell, KJ
    Schumm, K
    Perkins, ND
    EMBO JOURNAL, 2005, 24 (06): : 1157 - 1169